Cerebrospinal Fluid Liquid Biopsy Enables Targeted Therapy Without Tissue Diagnosis in Pediatric Low‐Grade Gliomas With BRAF V600E Mutation
Pediatric Blood & Cancer · 2026
DOI: 10.1002/1545-5017.70093 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pediatric Blood & Cancer, 2026. Verfasst von Hannah Sultan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosciences, Division of Child Neurology, University of Montreal, CHU Sainte-Justine, Montreal, Canada. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins B-raf, Glioma, Mutation, Brain Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
We present two pediatric cases of pediatric low‐grade gliomas (PLGG) with BRAF V600E mutations diagnosed and monitored using cerebrospinal fluid (CSF) liquid biopsy analyzed via digital droplet PCR (ddPCR), without tissue biopsy. Both patients were treated with dabrafenib and trametinib and monitored through clinical assessments, magnetic resonance imaging (MRI), and repeat CSF analyses. Both patients showed rapid and sustained clinical and radiological improvement following targeted therapy. In one case, follow‐up CSF analysis 3 months post‐treatment initiation was negative for BRAF V600E, indicating a potential role for liquid biopsy in monitoring treatment response. No significant toxicity was observed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosciences, Division of Child Neurology, University of Montreal, CHU Sainte-Justine, Montreal, Canada.
- Department of Pediatrics, McGill University and the Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
- Department of Surgery, Division of Neurosurgery, University of Montreal, CHU Sainte-Justine, Montreal, Canada.
ORCID-Profile: Sébastien Perreault
Zitieren
APA
Sultan, H., Faury, D., Weil, A. G., Westwick, H. J., Jabado, N., & Perreault, S. (2026). Cerebrospinal Fluid Liquid Biopsy Enables Targeted Therapy Without Tissue Diagnosis in Pediatric Low‐Grade Gliomas With BRAF V600E Mutation. Pediatric Blood & Cancer. https://doi.org/10.1002/1545-5017.70093
Vancouver
Sultan H, Faury D, Weil AG, Westwick HJ, Jabado N, Perreault S. Cerebrospinal Fluid Liquid Biopsy Enables Targeted Therapy Without Tissue Diagnosis in Pediatric Low‐Grade Gliomas With BRAF V600E Mutation. Pediatric Blood & Cancer. 2026. doi:10.1002/1545-5017.70093
BibTeX
@article{Sultan2026,
author = {Sultan, Hannah and Faury, Damien and Weil, Alexander G and Westwick, Harrison J and Jabado, Nada and Perreault, Sébastien},
title = {Cerebrospinal Fluid Liquid Biopsy Enables Targeted Therapy Without Tissue Diagnosis in Pediatric Low‐Grade Gliomas With BRAF V600E Mutation},
journal = {Pediatric Blood & Cancer},
year = {2026},
doi = {10.1002/1545-5017.70093}
}
EUVIMED